Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002;90:e11-e16
Published online before print December 6, 2001, doi: 10.1161/hh0102.102977
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/1/e11    most recent
hh0102.102977v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baroudi, G.
Right arrow Articles by Chahine, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baroudi, G.
Right arrow Articles by Chahine, M.
Related Collections
Right arrow Arrythmias-basic studies
Right arrow Ion channels/membrane transport
Right arrow Arrhythmias, clinical electrophysiology, drugs
(Circulation Research. 2002;90:e11.)
© 2002 American Heart Association, Inc.


UltraRapid Communications

Expression and Intracellular Localization of an SCN5A Double Mutant R1232W/T1620M Implicated in Brugada Syndrome

Ghayath Baroudi, Said Acharfi, Chantal Larouche, Mohamed Chahine

From the Department of Medicine, Laval University and Québec Heart Institute, Laval Hospital Research Center, Sainte-Foy, Québec, Canada.

Correspondence to Dr M. Chahine, PhD, Laval Hospital Research Center, 2725 Chemin Sainte-Foy, Sainte-Foy, Québec, Canada G1V 4G5. E-mail Mohamed.Chahine{at}phc.ulaval.ca

Abstract

Brugada syndrome is an inherited cardiac disorder caused by mutations in the cardiac sodium channel gene, SCN5A, that leads to ventricular fibrillation and sudden death. This study reports the changes in functional expression and cellular localization of an SCN5A double mutant (R1232W/T1620M) recently discovered in patients with Brugada syndrome. Mutant and wild-type (WT) human heart sodium channels (hNav1.5) were expressed in tsA201 cells in the presence of the ß1-auxiliary subunit. Patch-clamp experiments in whole-cell configuration were conducted to assess functional expression. Immunohistochemistry and confocal microscopy were used to determine the spatial distribution of either WT or mutant cardiac sodium channels. The results show an abolition of functional sodium channel expression of the hNav1.5/R1232W/T1620M mutant in the tsA201 cells. A conservative positively charged mutant, hNav1.5/R1232K/T1620M, produced functional channels. Immunofluorescent staining showed that the FLAG-tagged hNav1.5/WT transfected into tsA201 cells was localized on the cell surface, whereas the FLAG-tagged hNav1.5/R1232W/T1620M mutant was colocalized with calnexin within the endoplasmic reticulum (ER). These results indicate that a positively charged arginine or lysine residue at position 1232 in the double mutant is required for the proper transport and functional expression of the hNav1.5 protein. These results support the concept that loss of function of the cardiac Na+ channel is responsible for the Brugada syndrome. The full text of this article is available at http://www.circresaha.org.


Key Words: sodium channels • cardiac arrhythmias • protein trafficking • Brugada syndrome • ion channels




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Chen, M. Inoue, and M. F. Sheets
Reduced voltage dependence of inactivation in the SCN5A sodium channel mutation delF1617
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2666 - H2676.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Qu, G. Baroudi, Y. Yue, N. El-Sherif, and M. Boutjdir
Localization and modulation of {alpha}1D (Cav1.3) L-type Ca channel by protein kinase A
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2123 - H2130.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. L. Shang and S. C. Dudley Jr.
Tandem Promoters and Developmentally Regulated 5'- and 3'-mRNA Untranslated Regions of the Mouse Scn5a Cardiac Sodium Channel
J. Biol. Chem., January 14, 2005; 280(2): 933 - 940.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. J. Mohler, I. Rivolta, C. Napolitano, G. LeMaillet, S. Lambert, S. G. Priori, and V. Bennett
Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes
PNAS, December 14, 2004; 101(50): 17533 - 17538.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. L Tan, C. R Bezzina, J. P.P Smits, A. O Verkerk, and A. A.M Wilde
Genetic control of sodium channel function
Cardiovasc Res, March 15, 2003; 57(4): 961 - 973.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Fan, M. Liu, and Q. Wang
Functional Analysis of TBX5 Missense Mutations Associated with Holt-Oram Syndrome
J. Biol. Chem., February 28, 2003; 278(10): 8780 - 8785.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
B. Ye, C. R. Valdivia, M. J. Ackerman, and J. C. Makielski
A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutation
Physiol Genomics, February 6, 2003; 12(3): 187 - 193.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. R Bezzina and H. L Tan
Pharmacological rescue of mutant ion channels
Cardiovasc Res, August 1, 2002; 55(2): 229 - 232.
[Full Text] [PDF]